Spinal Fluids & Proteomic Markers
- A chronic fatigue syndrome - related proteome in human cerebrospinal fluid. Baraniuk, JN., Casado, B., Maibach, H., Clauw, DJ., Pannell, LK and Hess, S. BMC Neurology, 2005, 5:22. See diagram below.
- Schutzer SE, Angel TE, Liu T et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome. PLoS One 6(2), e17287 (2011); University of Medicine and Dentistry of New Jersey
- "The proteomic biosignature of ME/CFS in the cerebrospinal fluid shows the (quote)
"unbelievable" finding of unique markers that are complete
ly absent from the control group;
several proteins suggest amyloid deposition in the blood vessels of the brain, causing micro
-
haemorrhaging that occurs in conditions of chronic inflammation; another protein suggests
increased rates of apoptosis (programme
d cell death); another protein that was found suggests
problems with vasoconstriction and endothelial damage; one protein that was found is associated
with inflammation of the leptomeningeal cells in the membranes covering the brain and spinal
cord"
From presentations at the 8th
International Association of Chronic Fatigue Syndrome (IACFS)
Conference, Fort Lauderdale, Florida, held on 10
–
14 January 2007: J Baraniuk, Georgetown University, Washington DC
- Mathew, S. J., Mao, X., Keegan, K. A., Levine, S. M., Smith, E. L. P., Heier, L. A., Otcheretko, V., Coplan, J. D. and Shungu, D. C. (2009), Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T 1H MRS imaging study. NMR Biomed., 22: 251–258. See graph below:
- Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome. Steven E. Schutzer, Thomas E. Angel, Tao Liu, Athena A. Schepmoe, Therese R. Claus, Joshua N. Adkins, David G. Camp II, Bart K. Holland, Jonas Bergquist, Patricia K. Coyle, Richard D. Smith, Brian A. Fallon, Benjamin H. Natelson. (2011)
- Prevalence in the cerebro spinal fluid of the following infectious agents in a cohort of 12 CFS subjects: Human Herpes Virus 6 & 8; Chlamyclia Species; Mycoplasma Species, EBV; CMV and Coxsackie B Virus. Susan Levine JCFS 2001: 9: 91-2:41-51
|
